- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02794727
Physical Activity in the Medical Workplace (OPA)
April 16, 2020 updated by: Ivana Croghan, Mayo Clinic
Physical Activity in the Medical Workplace- a Way to Improve Physical and Mental Well-being?
Decreased physical activity is not only associated with multiple chronic medical conditions, including obesity, but also with depressed mood, and other negative emotions.
As many employed adults spend a great deal of time at work where we are predominantly sedentary, strategies to increase physical activity at work are being pursued to help improve the physical and mental health of Americans.
This 17 week randomized controlled trial will investigate changes of occupational physical activity in three groups: those provided with a FitBit® but not able to monitor their activity level, and those provided with activity goals and individual physical activity challenges, and those who do not use a FitBit®.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
All subjects will be entered into a 4 week run-in phase where subjects will wear a blinded Fitbit during work hours.
The baseline work activity is collected at this time.
This phase is followed by a randomization to one of 3 groups: the blinded Fitbit group, the unblinded Fitbit group, and the group which will not wear any activity monitors.
During these 12 weeks we will collect data on activity levels during work hours.
Everyone will have a final contact at week 17 to close out the study.
Study Type
Interventional
Enrollment (Actual)
135
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Be between 18 - 65 years of age
- Be a Mayo Clinic employee at 0.75 FTE or more
- Have no previous use of any activity monitor for 14 consecutive days or more
- Not be pregnant by subject self report
- Have a stable weight - defined as self-reported weight that has not changed more than 10% in the past 3 months
- Not have any previous history of joint problems that limit free movement, as determined by the PI
- Be able to participate fully in all aspects of the study
- Have understood and signed study informed consent.
Exclusion Criteria:
- Have a known history of any condition or factor judged by the investigator to preclude participation in the study or which might hinder adherence or skew data collection - such as a position where they predominantly provide transport as part of their job.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Blinded Fitbit
Subjects will wear the physical activity monitor (fitbit) for 12 weeks but will be blinded to the monitor display.
|
Subjects will wear a blinded Fitbit to monitor activity while in the workplace for 12 weeks.
|
|
Active Comparator: Unblinded Fitbit
Subjects will wear the physical activity monitor (fitbit) for 12 weeks.
They will have access to the monitor display and will have consults with study physician to set goals for the duration of the study.
|
Subjects will be unblinded to the Fitbit display for 12 weeks with set activity goals.
|
|
No Intervention: No Fitbit
Subjects will not wear any activity monitor for 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Fitbit Step Count Per Day
Time Frame: Baseline through Week 16
|
change in number of daily steps as measured by the fitbit monitor
|
Baseline through Week 16
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Ivana T Croghan, PhD, Mayo Cinic
- Study Director: Ryan T Hurt, MD, PhD, Mayo Clinic
- Principal Investigator: Sanjeev Nanda, MD, Mayo Clinic
- Principal Investigator: Sara Bonnes, MD, Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2016
Primary Completion (Actual)
November 1, 2018
Study Completion (Actual)
April 1, 2019
Study Registration Dates
First Submitted
June 2, 2016
First Submitted That Met QC Criteria
June 6, 2016
First Posted (Estimate)
June 9, 2016
Study Record Updates
Last Update Posted (Actual)
April 29, 2020
Last Update Submitted That Met QC Criteria
April 16, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 15-003049
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Physical Activity
-
Muğla Sıtkı Koçman UniversityEge UniversityCompletedPhysical Activity | Physical Activity Behavior | Physical Activity LevelsTurkey
-
Istinye UniversityCompletedPhysical Activity | Youth | Physical Activity Barriers | Physical Activity FacilitatorsTurkey
-
University of ManitobaResearch ManitobaCompletedPhysical Activity | Physical Activity Self-Definition
-
Universidad Pedagogica Nacional, ColombiaEnrolling by invitationPhysical Activity | Running | Running Performance | Running Endurance | Physical Activity in Adults | Physical Activity IntensityColombia
-
Istanbul Kültür UniversityWithdrawnPhysical Activity Level | Physical Activity Awareness
-
Universidade do PortoActive, not recruitingPhysical Activity | Physical Fitness | Well BeingPortugal
-
Odense University HospitalUniversity of Southern DenmarkRecruitingQuality of Life | Physical Activity | Physical Disability | Physical Function | ParticipationDenmark
-
Firat UniversityNot yet recruitingUniversity Students | Physical Activity Level | Postural Awareness | Physical Activity AttitudeTurkey
-
Georgetown UniversityUniversity of PennsylvaniaCompletedPhysical Activity | Motor ActivityUnited States
-
Pham Ngoc Thach University of MedicineCompletedModerate Physical Activity (MPA) | Vigorous Physical Activity (VPA) | Moderate to Vigorous Physical Activity (MVPA) | Total of Sleep Time (TST)Vietnam
Clinical Trials on Blinded Fitbit
-
The London Spine CentreUnknownLumbar Degenerative Spinal StenosisCanada
-
Ohio State UniversityNational Institute of Nursing Research (NINR); National Institutes of Health...CompletedCardiovascular Diseases | Physical Activity | Kidney Transplant; Complications | Cardiorenal; ChangeUnited States
-
University of South CarolinaCompletedArthroplasty, Replacement, KneeUnited States
-
AstraZenecaActive, not recruitingSystemic Sclerosis | SclerodermaUnited States, Canada, Italy, India, Belgium, France, Germany, Vietnam, China, Malaysia, South Africa, Austria, Israel, Netherlands, Spain, Japan, Hungary, United Kingdom, Poland, Mexico, Romania, South Korea, Turkey (Türkiye)
-
Seattle Children's HospitalCompleted
-
California Polytechnic State University-San Luis...CompletedCancer | Physical Activity | IncentivesUnited States
-
Seattle Children's HospitalFred Hutchinson Cancer CenterCompletedQuality of Life | Physical ActivityUnited States
-
Woman'sDexCom, Inc.TerminatedPostpartum Gestational Diabetes MellitusUnited States
-
University of IowaNational Heart, Lung, and Blood Institute (NHLBI)CompletedSedentary Lifestyle